Table of Contents
Implications for Psychiatric Care of the Word ‘Recovery’ in People with Bipolar Disorder
Erin E. Michalak, PhD; Rachelle Hole, PhD; Cindy Holmes, PhD Candidate; Vytas Velyvis, PhD Candidate; Jehannine Austin, PhD; Barbara Pesut, PhD; and Sharon Hou, BA
Cardiometabolic Health in Bipolar Disorder
David E. Kemp, MD, MS; and Jinbo Fan, PhD
Bipolar Disorder through Pregnancy and Postpartum
Wendy Marsh, MD, MS; and Adele Viguera, MD, MPH
Implications and Strategies for Clinical Management of Co-occurring Substance Use in Bipolar Disorder
Bryan K. Tolliver, MD, PhD; and Karen J. Hartwell, MD
Sponsorship Statement: This CME activity is jointly sponsored by Vindico Medical Education and Psychiatric Annals.
Support Statement: There is no commercial support for this activity.
Learning Objectives: Learning objectives are found at the beginning of each CME article.
Faculty names and affiliations: See authors above
Reviewer names: Jan Fawcett, MD, Editor, Psychiatric Annals; Andrew A. Nierenberg, MD, CME Coordinator, Psychiatric Annals
Guest Editor: Martha Sajatovic, MD
Disclosure statement: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.
Faculty, reviewer and staff disclosures: William E. Bunney, Jr., MD, has disclosed no relevant financial relationships. Jan Fawcett, MD, has disclosed the following relevant financial relationships: Merck: Member of Editorial Advisory Board, Merck Manual. Paula Hensley, MD, has disclosed the following relevant financial relationships: Astra-Zeneca: Consultant; and Merck and Pfizer: Member of speakers’ bureau. Robert Hirschfield, MD, has disclosed no relevant financial relationships. Eric Hollander, MD, has disclosed the following relevant financial relationships: Bristol-Myers Squibb (BMS), Nastech, Neuropharm, and Transcept: Consultant. Alan I. Levenson, MD, has disclosed no relevant financial relationships. Carl P. Malmquist, MD, has disclosed no relevant financial relationships. Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Abbott, Brain Cells, BMS, Eli Lilly, GlaxoSmithKline (GSK), Innapharma, PGx, Ortho-McNeil Janssen, Novartis, Pfizer, Sepracor, Shire, and Somerset: Member of Advisory Board/Consultant; Massachusetts General Hospital Structured Interview Guide to the Montgomery-Åsberg Rating Scale, and the Clinical Positive Affect Scale, licensed exclusively to the MGH Clinical Trials Network and Institute: Copyright Holder; BMS, Cederroth, Cyberonics, Eli Lilly, Forest, GSK, Ortho-McNeil, Lichtwer, NARSAD, NIMH, Pfizer, Stanley Foundation, and Wyeth: Research Grant Recipient; and BMS, Cyberonics, Eli Lilly, Forest, GSK, and Wyeth: Member of Speakers’ Bureau. The staff of Vindico Medical Education and psychiatric annals have disclosed no relevant financial relationships. Signed disclosures are on file at Vindico Medical Education.
Accreditation statement(s): This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Psychiatric Annals. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
Credit designation: Vindico Medical Education designates this Journal-based CME activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: May 1, 2012.
Expiration Date: May 31, 2013.
How to participate: To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 80% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Target audience: This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives and author disclosures are found at the beginning of each CME article.
Unlabeled and investigational usage statement: The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.
Copyright statement: Copyright © 2012 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.